Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
06/10/2009 | CN100497366C Process for extracting cyclic adenosine monophosphate (cAMP) from Chinese date |
06/09/2009 | US7544794 Method for sequencing DNA and RNA by synthesis |
06/09/2009 | CA2352229C Glyceryl nucleotides, method for the production thereof and their use |
06/04/2009 | WO2009069291A1 Prophylactic and/or therapeutic composition for disease caused by inhalation of tobacco smoke |
06/04/2009 | WO2001055301A3 Nucleic acids, proteins, and antibodies |
06/04/2009 | CA2706432A1 Antiviral nucleoside compounds |
06/03/2009 | CN101448846A Method for purification of cytidinediphosphoric choline |
06/03/2009 | CN100494212C Indolopyrrolocabazole derivative and antitumor agent |
06/02/2009 | US7541448 Oligonucleotides containing molecular rods |
06/02/2009 | US7541444 Invention relates to nucleotide or nucleoside molecules modified by reversible covalent attachment of 3'-OH blocking groups thereto, and which molecules may be used in reactions where blocked nucleotide or nucleoside molecules are required, such as in sequencing reactions, polynucleotide synthesis |
06/02/2009 | CA2534024C Novel compounds having inhibitory activity against sodium-dependant transporter |
05/28/2009 | WO2009067409A1 2',4'-substituted nucleosides as antiviral agents |
05/28/2009 | WO2009067035A2 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition |
05/28/2009 | WO2009066447A1 Light-responsive artificial nucleotide having photo-crosslinking ability |
05/28/2009 | WO2009066298A1 Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof |
05/28/2009 | WO2008043426A3 Components and method for enzymatic synthesis of nucleic acids |
05/28/2009 | US20090137791 solid phase synthesis of oligonucleotides and peptides on silicon chips, multiwell plates, glass beads |
05/28/2009 | US20090137521 Certain Compounds, Compositions and Methods |
05/28/2009 | US20090137520 Cardiovascular disorders such as tachycardia and atrial flutter, angina, myocardial infarction, diabetes, obesity, ischemia; for example 4-[N-({9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-hydroxymethyl)tetrahydrofuran-2-yl]-6-(cyclopentylamino)purin-2-yl}methyl)carbamoyl]benzenesulfonic acid |
05/28/2009 | US20090137419 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
05/28/2009 | US20090136940 Phosphoramidite nucleoside analogs |
05/28/2009 | CA2706327A1 2',4'-substituted nucleosides as antiviral agents |
05/28/2009 | CA2706222A1 Light-responsive artificial nucleotide having photo-crosslinking ability |
05/27/2009 | EP2061316A2 Azole nucleosides and use as inhibitors of rna and dna varial polymerases |
05/27/2009 | EP1594987B1 Nucleic acid sequencing methods, kits and reagents |
05/27/2009 | EP1141409B2 A kit and methods for nucleic acid sequencing of single molecules by polymerase synthesis |
05/27/2009 | EP1121371B1 Nucleotide compounds including a rigid linker |
05/27/2009 | CN101443332A Anti-viral pyrimidine nucleoside derivatives |
05/27/2009 | CN101440111A Anti-tumor compound and preparation thereof |
05/27/2009 | CN100490818C Methods for treating hepatitis delta virus infection with beta-L-2' deoxy-uncleosides |
05/26/2009 | US7537751 cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; genetic probes for real-time detection |
05/26/2009 | CA2337225C Novel antibacterial compounds |
05/21/2009 | US20090131652 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof |
05/21/2009 | US20090131651 Synthesis of 2-substituted adenosines |
05/21/2009 | US20090131370 Novel Nucleoside Derivatives |
05/21/2009 | US20090131342 Nitrosated and/or nitrosylated compounds, compositions and methods of use |
05/21/2009 | US20090130214 Gemcitabine derivatives nanoparticles |
05/20/2009 | CN101437935A Method of producing s-adenosyl-l-methionine-containing dry yeast having excellent storage stability, the product thereof and composition for oral intake |
05/20/2009 | CN101437397A Nucleotide and oligonucleotide prodrugs |
05/20/2009 | CN101434628A Process for synthesizing L-beta-5-methyl uracil riboside |
05/20/2009 | CN101434627A 2'-fluoro-4'-substituted nucleoside analogue, synthetic method and use thereof |
05/20/2009 | CN100488978C A continuous extraction method of effective ingredients from fruitbodies of Cordyceps militaris |
05/20/2009 | CN100488977C Technology of producing cytidine by chemical synthesizing process |
05/20/2009 | CN100488516C Use of compound in preparing medicament for pancreatic cancer treatment |
05/19/2009 | US7534771 Tricyclic-nucleoside prodrugs for treating viral infections |
05/14/2009 | WO2009061941A2 Baseless nucleotide analogues and uses thereof |
05/14/2009 | WO2009061781A1 Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors |
05/14/2009 | WO2009060063A1 Anthelmintic combination |
05/14/2009 | WO2008088779A3 Solid state forms of 5-azacytidine and processes for preparation thereof |
05/14/2009 | WO2006012624A3 Mechanism-based crosslinkers |
05/14/2009 | US20090124797 Novel synthesis of beta-nucleosides |
05/14/2009 | US20090124796 Nucleobase Having Perfluoroalkyl Group and Process for Producing the Same |
05/14/2009 | US20090123922 Bead Bound Combinatorial Oligonucleoside Phosphorothioate And Phosphorodithioate Aptamer Libraries |
05/14/2009 | US20090123388 Prodrugs of Short-Chain Fatty Acids and Treatment Methods |
05/14/2009 | CA2705092A1 Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors |
05/13/2009 | EP2057175A2 Nucleotide analogs |
05/13/2009 | EP1560838B1 Labelled nucleotides |
05/13/2009 | EP1495325B1 Use of nucloeoside derivatives comprising a citrate group for producing antibodies having affinity for triphosphorylated nucleosides and uses thereof |
05/13/2009 | EP1317464B1 Fluorescent nucleobase conjugates having anionic linkers |
05/13/2009 | EP1117838B1 A method for analyzing polynucleotides |
05/13/2009 | CN101429262A Porous resin particle having hydroxy group or primary amino group and production method thereof |
05/13/2009 | CN101429261A Production method of porous resin bead |
05/13/2009 | CN101429223A Process for producing novel growth regulator for pig |
05/13/2009 | CN101429215A Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside |
05/13/2009 | CN100486987C Antivira and antitumor deoxyoligonucleotide containing CpG single strand |
05/12/2009 | US7531525 Administering the salt, which is a P2Y purinergic receptor agonist that is hydrolysis-resistant to stimulate the removal of pathological fluid accumulation |
05/12/2009 | US7531509 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies |
05/12/2009 | CA2312099C New fluorescent cyanine labels containing a sulfamido linker arm |
05/07/2009 | WO2009029888A3 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |
05/07/2009 | US20090118491 Stable salt of 3'-phosphoadenosine 5'-phosphosulfate for use as enhanced sulfate donor in pharmaceutical products or health foods |
05/07/2009 | US20090118481 High Affinity Nucleic Acid Ligands To Lectins |
05/07/2009 | US20090118224 Agent against psychosocial stresses |
05/07/2009 | US20090118223 Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives |
05/07/2009 | US20090118222 Novel pyrimidine nucleoside compound or its salt |
05/07/2009 | US20090118221 Method of treating arrhythmias |
05/07/2009 | US20090118220 Substituted adenines and the uses thereof |
05/07/2009 | US20090117204 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
05/07/2009 | US20090117041 Radiologic Agents for Monitoring Alzheimer's Disease Progression and Evaluating a Response to Therapy and Processes for the Preparation of Such Agents |
05/06/2009 | EP2055711A1 Use of squalenic acid for the formulation of an active principle in nanoparticle state |
05/06/2009 | EP2054415A1 Adenosine receptor antagonists |
05/06/2009 | EP1572711B1 Anhydrous crystalline azido cytosine hemisulfate derivative |
05/06/2009 | EP1212457B1 Uv excitable fluorescent energy transfer dyes |
05/06/2009 | CN101423540A Cytarabin 5'-O-L-valine ester and pharmaceutically acceptable salt as well as preparation and application thereof |
05/06/2009 | CN100484950C Purification of 2-iodo-6-chloro-9-beta(2',3',5'-trioxyacetyl-D-furanose)purine |
05/06/2009 | CN100484949C Nucleoside phosphoramidite used in RNA oligo-nucleotide synthesis and its synthesizing method |
05/05/2009 | US7528247 Process for preparing purine nucleosides |
05/05/2009 | US7528115 Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidines |
04/30/2009 | WO2009053654A2 Gemcitabine phosphoester prodrugs as anticancer agents |
04/30/2009 | WO2008109080A3 Nucleoside based proliferation imaging markers |
04/30/2009 | WO2007056213A3 Drug-eluting stents coated with p2y12 receptor antagonist compound |
04/30/2009 | US20090111979 Modified 5'- phosphonate azidothymidine - potential anti-viral preparations |
04/30/2009 | US20090110671 Agent for enhanching the production of collagen and it's use |
04/29/2009 | EP2053054A1 Method for introducing nucleic-acid-protecting group |
04/29/2009 | EP1425022A4 Mutagenic nucleoside analogs for the treatment of viral disease |
04/29/2009 | CN101421289A Method for removal of nucleic acid-protecting group |
04/29/2009 | CN101420959A Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine A2A receptor agonists |
04/29/2009 | CN101418028A Synthesis of beta-l-2-deoxy nucleosides |
04/29/2009 | CN100482236C Beta-L-2'-dioxidition-nucleoside for treating hepatitis B |
04/28/2009 | US7524942 For analysis of ligated RNA |
04/28/2009 | US7524825 Tricyclic-nucleoside compounds for treating viral infections |